{"id":547325,"date":"2022-06-16T03:58:38","date_gmt":"2022-06-16T03:58:38","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/"},"modified":"2022-06-16T03:58:38","modified_gmt":"2022-06-16T03:58:38","slug":"rameda-gets-its-hands-on-a-new-molecule","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/","title":{"rendered":"Rameda gets its hands on a new molecule"},"content":{"rendered":"<p><strong>Rameda has acquired a molecule used for treating epilepsy<\/strong>, the pharma company said in <a href=\"\">a disclosure to the EGX (pdf)<\/a> yesterday. Known as Lacovimp, the molecule reduces the frequency and severity of partial seizures and was described by the company as \u201cthe fastest-growing product within the local market for its corresponding API\u201d with a CAGR of 226% between 2019 and 2021. The product is sold for EGP 136-234 depending on the dosage, and is expected to generate EGP 24 mn in annual revenues for the company.<\/p>\n<p><strong>Real estate developers will be able to offer mortgage financing for customers on <\/strong><strong>units still under construction<\/strong>, after the Financial Regulatory Authority (FRA) approved a mandate to help grow mortgage financing and expand its use, according to a <a href=\"\">press release (pdf)<\/a>.<\/p>\n<p><strong>Other things we\u2019re keeping an eye on this morning:<\/strong><\/p>\n<ul>\n<li><strong><a href=\"https:\/\/power.mhi.com\/\">Mitsubishi Power<\/a><\/strong> will supply hydrogen fuel conversion tech to <strong>Alexandria <\/strong><strong>National Refining & Petrochemicals Company<\/strong> (ANRPC), enabling it to go 100% hydrogen by the end of 2023. The company\u2019s refinery provides 30% of the country\u2019s gasoline supply. (<a href=\"https:\/\/www.zawya.com\/en\/press-release\/companies-news\/mitsubishi-power-signs-decarbonization-agreement-for-hydrogen-fuel-conversion-adjmyiz9\">Statement<\/a>)<\/li>\n<li>Indian clean energy company <strong><a href=\"https:\/\/www.acme.in\/\">Acme<\/a><\/strong> is looking at potential green investments in Egypt. (<a href=\"https:\/\/www.facebook.com\/EgyptianCabinet\/posts\/427256379444788\">Statement<\/a>)<\/li>\n<li><strong>Fawry <\/strong>has launched its <strong>Cash-in & Cash-out service <\/strong>in cooperation with the Egyptian Banks Company and Banque Misr. (<a href=\"https:\/\/ent.news\/2022\/6\/FAWRY-Ar-PR.pdf\">Statement, pdf<\/a>)<\/li>\n<li><strong>Aman for Microfinance<\/strong> launched its first investment fund <strong>\u201cAman <\/strong><strong>Youm-B-Youm\u201d<\/strong> with <strong>Prime Investments<\/strong>. (<a href=\"https:\/\/ent.news\/2022\/6\/AMAN-YOUM-B-YOUM-ENGLISH.pdf\">Statement, pdf<\/a>)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Rameda has acquired a molecule used for treating epilepsy, the pharma company said in a disclosure to the EGX (pdf) yesterday. Known as Lacovimp, the molecule reduces the frequency and severity of partial seizures and was described by the company as \u201cthe fastest-growing product within the local market for its corresponding API\u201d with a CAGR [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[7209],"tags":[111,93,72,519,76,254,2061,427,449],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-547325","post","type-post","status-publish","format-standard","hentry","category-also-on-our-radar","tag-also-on-our-radar","tag-energy","tag-enterpriseam","tag-fawry","tag-financial-regulatory-authority","tag-green-hydrogen","tag-mortgage-finance","tag-pharma","tag-rameda-pharma","wpautop","entry"],"acf":{"mongo_id":"2a9153f3-87e1-4db1-bd78-61e2abf87cc0","is_powered_by":true,"story_type":"1","photo_url":"","photo_position":"above","related_issue":[547300],"teaser":"","voice_url":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Rameda gets its hands on a new molecule - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rameda gets its hands on a new molecule\" \/>\n<meta property=\"og:description\" content=\"Rameda has acquired a molecule used for treating epilepsy, the pharma company said in a disclosure to the EGX (pdf) yesterday. Known as Lacovimp, the molecule reduces the frequency and severity of partial seizures and was described by the company as \u201cthe fastest-growing product within the local market for its corresponding API\u201d with a CAGR [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-16T03:58:38+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Rameda gets its hands on a new molecule\",\"datePublished\":\"2022-06-16T03:58:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\"},\"wordCount\":225,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"ALSO ON OUR RADAR\",\"energy\",\"EnterpriseAM\",\"Fawry\",\"Financial Regulatory Authority\",\"green hydrogen\",\"mortgage finance\",\"pharma\",\"Rameda Pharma\"],\"articleSection\":[\"Also on our Radar\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\",\"name\":\"Rameda gets its hands on a new molecule - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2022-06-16T03:58:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rameda gets its hands on a new molecule\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rameda gets its hands on a new molecule - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/","og_locale":"en_US","og_type":"article","og_title":"Rameda gets its hands on a new molecule","og_description":"Rameda has acquired a molecule used for treating epilepsy, the pharma company said in a disclosure to the EGX (pdf) yesterday. Known as Lacovimp, the molecule reduces the frequency and severity of partial seizures and was described by the company as \u201cthe fastest-growing product within the local market for its corresponding API\u201d with a CAGR [&hellip;]","og_url":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2022-06-16T03:58:38+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Rameda gets its hands on a new molecule","datePublished":"2022-06-16T03:58:38+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/"},"wordCount":225,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["ALSO ON OUR RADAR","energy","EnterpriseAM","Fawry","Financial Regulatory Authority","green hydrogen","mortgage finance","pharma","Rameda Pharma"],"articleSection":["Also on our Radar"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/","url":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/","name":"Rameda gets its hands on a new molecule - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2022-06-16T03:58:38+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2022\/06\/16\/rameda-gets-its-hands-on-a-new-molecule\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Rameda gets its hands on a new molecule"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":570490,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/04\/02\/rameda-acquires-generic-anti-inflammatory-molecule\/","url_meta":{"origin":547325,"position":0},"title":"Rameda acquires generic anti-inflammatory molecule","author":"enterpriseam admin","date":"2 April 2020","format":false,"excerpt":"Rameda Pharma has acquired a generic anti-inflammatory molecule, according to a statement (pdf). The unnamed molecule, which relieves pain associated with rheumatoid arthritis, psoriatic arthritis, osteoarthritis and other chronic ailments, would have been among Rameda\u2019s top-10 selling products had it been in its lineup in 2019. An independent market research\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":566832,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/","url_meta":{"origin":547325,"position":1},"title":"Rameda acquires new molecule, Dana gas isn\u2019t complaining","author":"enterpriseam admin","date":"15 July 2021","format":false,"excerpt":"EGX-listed Rameda Pharma has acquired an new anticoagulant molecule, the company said in a press release this morning (pdf). The company didn\u2019t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with \u201can established market presence.\u201d The company said the\u2026","rel":"","context":"In &quot;SPEED ROUND: CATCH UP QUICK&quot;","block_context":{"text":"SPEED ROUND: CATCH UP QUICK","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-catch-up-quick\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":560270,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/22\/ibnsina-to-distribute-bayer-meds-in-egypt-rameda-looks-to-invest\/","url_meta":{"origin":547325,"position":2},"title":"Ibnsina to distribute Bayer meds in Egypt, Rameda looks to invest","author":"enterpriseam admin","date":"22 February 2021","format":false,"excerpt":"Ibnsina Pharma has signed an agreement with Germany\u2019s Bayer to import and distribute products from its OTC and Rx-based portfolios, the companies said in a joint statement (pdf) today. Bayer wants to grow in Egypt: Bayer Consumer Health wants to increase sales by 30% in 2021 after recording sales of\u2026","rel":"","context":"In &quot;PHARMA&quot;","block_context":{"text":"PHARMA","link":"https:\/\/enterpriseam.com\/egypt\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/314.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":603779,"url":"https:\/\/enterpriseam.com\/egypt\/2023\/08\/21\/rameda-eyes-majority-stakes-in-two-companies\/","url_meta":{"origin":547325,"position":3},"title":"Rameda eyes majority stakes in two companies","author":"enterpriseam admin","date":"21 August 2023","format":false,"excerpt":"The company is eyeing a pharma company and a cosmeceuticals firm","rel":"","context":"In &quot;M&amp;A WATCH&quot;","block_context":{"text":"M&amp;A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2023\/8\/939.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":595175,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/09\/18\/is-rameda-pharma-the-mysterious-pharma-company-planning-a-usd-61mn-ipo\/","url_meta":{"origin":547325,"position":4},"title":"Is Rameda Pharma the mysterious pharma company planning a USD 61mn IPO?","author":"enterpriseam admin","date":"18 September 2019","format":false,"excerpt":"IPO WATCH- Is Rameda Pharma the mysterious pharma company planning a USD 61mn IPO? Remember that unnamed pharma company that Financial Regulatory Authority official Sayed Abdel Fadeel said is planning a USD 61 mn initial public offering on the EGX this year? Well, Al Mal is speculating that the company\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":593231,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/21\/rameda-receives-greenlight-for-ipo-this-year\/","url_meta":{"origin":547325,"position":5},"title":"Rameda receives greenlight for IPO this year","author":"enterpriseam admin","date":"21 November 2019","format":false,"excerpt":"IPO WATCH- Rameda gets nod for share listing, will go public before the end of the year \u2013FRA: Rameda Pharma has received approval from the Financial Regulatory Authority (FRA) to go public on the EGX before the end of this year, FRA boss Mohamed Omran said at a press conference\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2019\/8\/EGX-1600px.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/547325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=547325"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/547325\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/547300"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=547325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=547325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=547325"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=547325"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=547325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}